4LL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teladoc Health Inc

Watchlist Manager

Watchlist

Price: 5.246 EUR -1.87%

Market Cap: €897.7m

T	Teladoc Health Inc F:4LL	US
T	Takeda Pharmaceutical Co Ltd XHAM:TKD	JP
T	Takeda Pharmaceutical Co Ltd F:TKDA	JP
	Perrigo Company PLC F:PIG	IE

Profitability Summary

Teladoc Health Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

70%

Declining Gross Margin

70% > 69%

Negative Operating Margin

-6%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-9% > -6%

Negative Net Margin

-7%

Negative 3Y Average Net Margin

-31%

Net Margin is Increasing

-159% > -7%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

3% > 5%

Negative ROE

-13%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

-4% > -7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.